Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242438 (US9422235, 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 6 | -47.7 | 11 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242480 (US9422235, 58) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 12.2 | -45.9 | 20 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242430 (US9422235, 3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 17 | -45.1 | 30 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242525 (US9422235, 110) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 18.8 | -44.8 | 37.2 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242431 (US9422235, 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 19 | -44.8 | 37 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242504 (US9422235, 87) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 23 | -44.3 | 37 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242465 (US9422235, 41) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 28 | -43.8 | 48.8 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242435 (US9422235, 9) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 28 | -43.8 | 50 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242467 (US9422235, 43) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 29 | -43.7 | 50.2 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242431 (US9422235, 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 29 | -43.7 | 56 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242431 (US9422235, 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 29.2 | -43.7 | 58.1 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242465 (US9422235, 41) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 32.4 | -43.5 | 64.5 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242504 (US9422235, 87) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 33 | -43.4 | 78 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242431 (US9422235, 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 34 | -43.3 | 76 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242465 (US9422235, 41) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 34.8 | -43.3 | 53.1 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242450 (US9422235, 26) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 36 | -43.2 | 75 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242431 (US9422235, 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 37 | -43.1 | 68 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242437 (US9422235, 11) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 37 | -43.1 | 72 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242435 (US9422235, 9) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 38 | -43.1 | 84 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242492 (US9422235, 73) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 43.3 | -42.7 | 95.6 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242520 (US9422235, 105) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 49 | -42.4 | 83.4 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242460 (US9422235, 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 53 | -42.2 | 106 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242505 (US9422235, 88) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 56 | -42.1 | 91 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242523 (US9422235, 108) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 58 | -42.0 | 95 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242468 (US9422235, 44) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 62 | -41.8 | 109 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242460 (US9422235, 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 66 | -41.7 | 132 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242460 (US9422235, 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 68 | -41.6 | 132 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242493 (US9422235, 74) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 69.2 | -41.6 | 153 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242471 (US9422235, 47) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 75.1 | -41.3 | 138 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242509 (US9422235, 92 | US9422235, 96) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 79 | -41.2 | 135 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242509 (US9422235, 92 | US9422235, 96) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 80 | -41.2 | 143 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242445 (US9422235, 21) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 81 | -41.2 | 180 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242456 (US9422235, 32) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 81 | -41.2 | 181 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242433 (US9422235, 6) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 84 | -41.1 | 179 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242511 (US9422235, 94) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 85 | -41.0 | 146 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242459 (US9422235, 35) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 87 | -41.0 | 206 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242434 (US9422235, 7) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 90 | -40.9 | 198 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242438 (US9422235, 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 97 | -40.7 | 235 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242452 (US9422235, 28) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 98 | -40.7 | 221 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242443 (US9422235, 19) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 113 | -40.3 | 255 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242522 (US9422235, 107) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 114 | -40.3 | 187 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242460 (US9422235, 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 131 | -39.9 | 215 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242466 (US9422235, 42) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 140 | -39.8 | 245 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242446 (US9422235, 22) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 146 | -39.7 | 332 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242453 (US9422235, 29) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 152 | -39.6 | 344 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242521 (US9422235, 106) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 156 | -39.5 | 264 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242436 (US9422235, 10) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 168 | -39.3 | 290 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242479 (US9422235, 57) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 175 | -39.2 | 327 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM242430 (US9422235, 3) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 180 | -39.1 | 313 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM242503 (US9422235, 86) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 186 | -39.1 | 431 | n/a | n/a | n/a | n/a | n/a | 30 |
Pharmos Corporation US Patent | Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis... | US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 171 total ) | Next | Last >> |